Please login to the form below
13
Revenue 2017Bristol-Myers Squibb
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bristol-Myers Squibb's 2013 sales performance.
FDA verdict on Sanofi’s Darzalex rival is due in April 2020
Additional competition is however looming from MorphoSys and Takeda, which each have anti-CD38 drugs in pivotal-stage testing for myeloma, while another rival is Bristol-Myers Squibb and AbbVie’s
Citryll snares €15m backing for its autoimmune disease NETs
Other companies including Bristol-Myers Squibb (via its $600m acquisition of Padlock Therapeutics in 2016) are working on small-molecule PAD inhibitors for autoimmune disease.
Gaining Perspective: What Can the UK Learn from Lung Cancer Care in Europe?
by ENGINE MHP for Bristol-Myers Squibb. The UK’s lung cancer survival rates are some of the lowest in Europe. To tackle this, the UK Lung Cancer Coalition (UKLCC) identified ... the possibility of learning from European health systems to improve
Illustrating Rheumatoid Arthritis
by ENGINE MHP for Bristol-Myers Squibb.
Securing Equity of Access to Cancer Medicines in Northern Ireland
by Hanover Communications for Bristol-Myers Squibb. In 2013, the Northern Ireland (NI) Government committed to follow the recommendations made by the National Institute for Health and Care Excellence (NICE). ... Securing Equity of Access to Cancer
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
- Client Partner, Healthcare Brand Communications, London
-
Highly competitive package
- Strategic Associate Director Healthcare PR, London
-
Substantiel package
- Publications Director, Medical Communications agency, Home Based...
-
Competitive Salary
- Publications Director, Medical Communications agency, Oxford
-
Competitive Salary
- Account Director, Healthcare Communications
-
Salary TBC
- Publications Director, Medical Communications agency, Cambridge
-
Competitive Salary
Subscribe to our email news alerts
- Kisqali combination follows Verzenio onto Cancer Drugs Fund
- Genentech taps into Sosei Heptares GPCR expertise with $1bn alliance
- ACPs to lead gene therapies in haemophilia market growth
- FDA starts speedy review of Novartis’ sickle cell antibody
- Recursion raises $121m for AI-led drug discovery
- AbbVie cures STING fever with Mavupharma acquisition
PMHub
GCI Health
GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...
Latest intelligence
- Precision paediatrics: Treating patients with CAR-T
- Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
- What does it mean to be an agile organisation
- We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
- Battling breast cancer with precision medicine (Part 2)
- Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...
Quick links
Infographics
